Rational antithrombotic therapy and prophylaxis in elderly, immobile patients

Area of Science:

• Gerontology
• Hematology
• Vascular Medicine

Background:

• Aging is linked to a 'prethrombotic state' with increased coagulation and fibrinolysis.
• Elderly patients have a higher susceptibility to thromboembolic disease, exacerbated by surgery or malignancy.
• Thromboembolic disease carries considerable mortality in the elderly, even with antithrombotic therapy.

Purpose of the Study:

• To review current prophylactic and therapeutic strategies for thromboembolic disease in the elderly.
• To highlight the importance of individualized risk assessment for antithrombotic interventions.
• To identify the need for specialized regimens for non-surgical high-risk elderly subgroups.

Main Methods:

• Review of existing literature on thromboembolic prophylaxis and treatment in elderly populations.
• Analysis of the efficacy of low molecular weight heparins (LMWHs) and compression stockings.
• Consideration of risk-benefit assessments for antithrombotic therapies.

Main Results:

• Low molecular weight heparins (LMWHs) are the most effective prophylaxis for elderly, immobile patients.
• Compression stockings aid in venous thrombosis prevention for moderate-risk surgical patients.
• Specific prophylaxis is crucial for orthopedic surgery patients, often requiring LMWH in addition.
• Initial treatment for venous thrombosis can involve weight-adjusted LMWH, followed by 6 months of oral anticoagulation for deep vein thrombosis or pulmonary embolism.

Conclusions:

• Effective thromboembolic prophylaxis and treatment are vital in the elderly due to their increased risk.
• Individualized risk assessment is essential before initiating antithrombotic therapy.
• Further research is needed to develop tailored prophylactic and therapeutic strategies for non-surgical high-risk elderly groups.